Does COVID‐19‐related cachexia mimic cancer‐related cachexia? Examining mechanisms, clinical biomarkers, and potential targets for clinical management
Saved in:
Main Author: | Nagi B. Kumar (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2021-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biomarker endpoints in cancer cachexia clinical trials: Systematic Review 5 of the cachexia endpoint series
by: Michael S. Yule, et al.
Published: (2024) -
Cachexia index as a potential biomarker for cancer cachexia and a prognostic indicator in diffuse large B‐cell lymphoma
by: Se‐Il Go, et al.
Published: (2021) -
Potential Biomarkers of Fat Loss as a Feature of Cancer Cachexia
by: Maryam Ebadi, et al.
Published: (2015) -
Towards Drug Repurposing in Cancer Cachexia: Potential Targets and Candidates
by: Joana M. O. Santos, et al.
Published: (2021) -
Biomarkers and mechanisms associated with cancer‐induced cardiac cachexia: A systematic review
by: Lisa Bagnall, et al.
Published: (2023)